Introduction
Viral infection triggers a series of cellular events that lead to induction of type I interferons (IFNs) and proinflammatory cytokines (Akira et al., 2006; Takeuchi and Akira, 2010) . Type I IFNs induce the expression of a set of IFN-stimulated genes (ISGs). The ISGs have inhibitory effects on viral replication or are capable of inducing apoptosis of infected cells, and therefore are crucial mediators of innate antiviral response (Levy and Marie, 2004; Honda and Taniguchi, 2006) . Viral infection is sensed by pattern recognition receptors (PRRs), which recognize structurally conserved pathogen-associated molecular patterns (PAMPs) of virus (Baccala et al., 2009) . Viral nucleic acids, including viral genomic RNA/DNA and replicating intermediates, act as typic PAMPs. It has been demonstrated that the endosomal membrane-associated TLR3 recognizes viral double-strand (ds) RNA in certain immune cells (Beutler et al., 2007; Fujita et al., 2007; Medzhitov, 2007) . However, in most cell types, the cytoplasmic RIG-I-like receptors (RLRs), including RIG-I and MDA5, play key roles in sensing RNA virus invasion (Andrejeva et al., 2004; Yoneyama et al., 2004) . Upon recognition of viral RNAs through their C-terminal RNA helicase domains, RIG-I and MDA5 undergo conformational changes and are recruited to the downstream mitochondria-associated adaptor protein VISA (also called MAVS, IPS-1, Cardif) through their respective CARD domains (Xu et al., 2005; O'Neill and Bowie, 2010) . VISA acts as a central platform and activates downstream TAK1-IKKb and TBK1/IKK1 kinases, leading to activation of NF-kB and IRF3 and induction of type I IFNs (Fitzgerald et al., 2003; Sharma et al., 2003; Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Ran et al., 2011; He et al., 2013) .
Although RIG-I and MDA5 share similar signaling features and structural homology (Yoneyama et al., 2004) , various studies have demonstrated that the two helicases may discriminate among different ligands to trigger the innate immune response to RNA viruses. Picornaviruses, such as encephalomyocarditis virus (EMCV), are specifically recognized by MDA5, whereas RIG-I recognizes a wide variety of RNA viruses belonging to the paramyxovirus and rhabdovirus families (Kato et al., 2006) . The synthetic analog of viral dsRNA, poly(I:C), which triggers innate immune response, was found to be a ligand for MDA5 (Gitlin et al., 2006; Kato et al., 2006) , whereas single-stranded (ss) RNA with 5 ′ -triphosphate and short dsRNA, such as RNase III-treated short poly(I:C), are ligands for RIG-I (Kato et al., 2008) . The mechanism of RIG-I-mediated antiviral signaling has been extensively investigated. However, little is known on how MDA5 activity is regulated beyond viral RNA binding. In the present study, we identified RAVER1 as a protein specifically associated with MDA5 but not RIG-I. Knockdown of RAVER1 potently inhibited MDA5-but not RIG-I-mediated type I IFN induction and innate antiviral response. Mechanistically, RAVER1 promoted the binding of MDA5 to poly(I:C). Our findings suggest that RAVER1 acts as a coactivator of MDA5-mediated IFN induction and provide insight into the mechanism of differential regulation of MDA5-and RIG-I-mediated antiviral responses.
Results

Identification of RAVER1 as a MDA5-associated protein
MDA5 is essential for innate immune response to certain viruses but the regulatory mechanisms of MDA5 activity have not been adequately characterized. To identify potential proteins that interact with MDA5 and regulate its activity, we performed tandem affinity purification (TAP) experiments with MDA5 as a bait protein. An expression plasmid for MDA5 tagged with calmodulin binding peptide (CBP) and streptavidin binding peptide (SBP) was stably transfected into 293 cells, and MDA5-associated proteins were purified by a TAP purification system. The eluted proteins were identified by a shot-gun mass spectrum analysis method. By comparing with other unrelated purifications using the same method, we identified RAVER1 as a protein specifically associated with MDA5 ( Figure 1) . Structurally, RAVER1 contains three RNA recognition motifs (RRMs), also known as RNA binding domains (RBDs). It has been shown that RAVER1 interacts with vinculin and RNA, which suggests a feed-forward pathway in directing mRNA to focal adhesions (Lee et al., 2009) .
To determine whether RAVER1 indeed interacts with MDA5, we performed transient transfection and coimmunoprecipitation assays. The results indicated that RAVER1 could interact with fulllength MDA5 and its CARD domain but not with its helicase domain ( Figure 2A) . Interestingly, RAVER1 interacted better with the CARD domain of MDA5 than the full-length MDA5 (Figure 2A ). In the same experiment, RAVER1 did not interact with full-length RIG-I, as well as its CARD or helicase domain (Figure 2A ). These results suggest that RAVER1 specifically interacts with MDA5.
To determine whether RAVER1 interacts with MDA5 in untransfected cells, we performed endogenous coimmunoprecipitation assays. Consistent with previous reports (Kang et al., 2004; Gitlin et al., 2010) , MDA5 was hardly detected in uninfected cells but markedly induced upon Sendai virus (SeV) infection for 12-24 h ( Figure 2B) . Results from endogenous coimmunoprecipitation assays indicated that endogenous RAVER1 was associated with endogenous MDA5 following SeV infection ( Figure 2B ).
To investigate whether RAVER1 directly binds to MDA5, we performed in vitro binding assays. Recombinant MDA5 and RAVER1 were synthesized by in vitro transcription and translation. The mixed proteins were immunoprecipitated with anti-MDA5 and the immunoprecipitates were analyzed by immunoblotting with anti-RAVER1. The results suggest that RAVER1 binds MDA5 directly ( Figure 2C ). Figure 1 Results of mass spectrum analysis. The purified MDA5-associated proteins were identified by a shot-gun mass spectrum analysis.
RAVER1 was identified from MDA5 but not other similar purifications. The two identified peptides of RAVER1 were indicated.
Overexpression of RAVER1 modulates MDA5-mediated activation of the IFN-b promoter
Because RAVER1 is specifically associated with MDA5, we examined whether RAVER1 is involved in regulation of MDA5-mediated signaling. In reporter assays, RAVER1 potentiated MDA5-mediated activation of the IFN-b promoter in a dosedependent manner at low dosages, whereas RAVER1 inhibited MDA5-mediated activation of the IFN-b promoter at high dosages ( Figure 3A) . In this experiment, high doses of RAVER1 caused cell death, which was evident from reduced levels of b-actin by immunoblot analysis ( Figure 3A) . Consistent with the result of coimmunoprecipitation assays, overexpression of RAVER1 did not have marked effect on RIG-I-mediated activation of the IFN-b promoter ( Figure 3B ).
RAVER1 is important for MDA5-mediated induction of downstream antiviral genes
Because overexpression of RAVER1 modulates MDA5-mediated activation of the IFN-b promoter, we next determined whether endogenous RAVER1 regulates MDA5-mediated induction of downstream antiviral genes. We constructed four human RAVER1-RNAi plasmids. Immunoblot analysis indicated that the #1, #3 and #4 RNAi plasmids could markedly inhibit the expression of transfected and endogenous RAVER1 in 293 cells, whereas the #2 RNAi plasmid had little effect on RAVER1 expression ( Figure 4A ). Previously, it has been demonstrated that SeV infection is sensed by both RIG-I and MDA5. Whereas long high molecular weight poly(I:C) is recognized by MDA5, short poly(I:C) or singlestranded (ss) RNA with 5 recognized by RIG-I (Gitlin et al., 2006; Kato et al., 2006 Kato et al., , 2008 Diao et al., 2007) . Therefore, we examined the effect of RAVER1 knockdown on signaling triggered by SeV, long poly(I:C), short poly(I:C) or 5 ′ ppp-ssRNA. As shown in Figure 4B , knockdown of RAVER1 inhibited SeV-induced activation of ISRE, NF-kB and the IFN-b promoter. Transcription induction of IFN-b requires coordinated and cooperative activation of both transcription factors IRF3 and NF-kB. Consistent with the results of reporter assays, knockdown of RAVER1 markedly inhibited SeV-induced phosphorylation of IRF3 and IkBa, which are hallmarks of IRF3 and NF-kB activation, respectively ( Figure 4C ). In these experiments, SeV-induced expression of MDA5 and RIG-I was also inhibited by knockdown of RAVER1 ( Figure 4C ). Similarly, knockdown of RAVER1 markedly inhibited activation of the IFN-b promoter, ISRE and Nifty (a NF-kB reporter) triggered by transfected cytoplasmic long poly(I:C) ( Figure 4D ), but had no marked effect on activation of ISRE and the IFN-b promoter triggered by transfected cytoplasmic short low molecular weight poly(I:C) ( Figure 4E promoter. As shown in Figure 4G , knockdown of TRIF had no marked effect on IFN-b promoter activation triggered by transfected cytoplasmic long poly(I:C) in 293 cells, but markedly inhibited IFN-b promoter activation triggered by long poly(I:C) in 293-TLR3 stable cell line. These results suggest that RAVER1 plays important roles in MDA5-but not RIG-I-mediated signaling. As shown in Figure 4 , the extent of inhibition by each RNAi plasmid on SeV or long poly(I:C) trigged signaling was correlated with the RAVER1 knockdown efficiency ( Figure 4A ). Further experiments with RAVER1-RNAi-#1 plasmid were described below and similar results were obtained with the #3 and #4 RNAi plasmids (data not shown). We further examined the effect of RAVER1 knockdown on the transcription of downstream genes triggered by SeV and cytoplasmic long poly(I:C). Real-time PCR experiments indicated that knockdown of RVAER1 inhibited SeV and cytoplasmic long poly(I:C)-induced transcription of downstream genes such as IFNB1, RANTES, TNFa and ICAMI in 293 cells ( Figure 5A and B). Previously, it has been shown that EMCV infection is specifically sensed by MDA5. In our study, knockdown of RAVER1 markedly inhibited the transcription of IFNB1, RANTES and ICAM1 genes triggered by EMCV infection in HCT116 cells ( Figure 5C ). Taken together, these data suggest that RAVER1 is required for MDA5-but not RIG-I-mediated induction of downstream antiviral genes.
RAVER1 is involved in MDA5-mediated cellular antiviral response
Because RAVER1 is specifically involved in MDA5-mediated signaling, we investigated whether RAVER1 plays a role in regulation of MDA5-mediated cellular antiviral response. In plaque assays, we found that knockdown of RAVER1 reversed the inhibitory effect on vesicular stomatitis virus (VSV) replication triggered by cytoplasmic long poly(I:C) ( Figure 5D ). Consistently, Newcastle disease virus (NDV) replication was also enhanced in RAVER1 knockdown cells ( Figure 5E ). These data suggest that RAVER1 plays an important role in MDA5-mediated cellular antiviral response. RAVER1 enhances the binding of MDA5 to long poly(I:C)
Since RAVER1 specifically regulates MDA5-mediated signaling, we reasoned that RAVER1 may modulate the binding of MDA5 to its ligand poly(I:C). In poly(I:C) pull-down assays, we found that poly(I:C) bound to MDA5 and RIG-I but not RAVER1 ( Figure 6A and B). However, overexpression of RAVER1 enhanced the binding of poly(I:C) to MDA5 but not to RIG-I ( Figure 6A and B) , whereas knockdown of RAVER1 decreased the binding of poly(I:C) to MDA5 ( Figure 6C ). These results suggest that RAVER1 acts as a coactivator of MDA5 by modulating the binding of MDA5 to its ligand.
Discussion
In most cell types, infection by RNA viruses is sensed by the cytoplasmic RNA helicase proteins RIG-I and MDA5, and results in induction of type I IFNs and other antiviral genes (Yoneyama et al., 2008) . Elucidation of the molecular events of RLRmediated induction of downstream antiviral genes is critical for understanding the complicated mechanisms of cellular antiviral innate immune response. Both RIG-I and MDA5 are induced upon viral infection. They also share similar structure architecture and mediate conserved downstream signaling pathways (Yoneyama et al., 2005; Eisenacher and Krug, 2012) . While the regulation of RIG-I activity has been extensively investigated, little is known on how MDA5 is regulated. Previously, one report suggests that the cytoplasmic protein dihydroxyacetone kinase (DAK) is associated with MDA5 and keeps MDA5 in an inactive status (Diao et al., 2007) . Obviously, further investigation of the regulatory mechanisms of MDA5 activity is needed, which is also important to understand how MDA5-and RIG-I-mediated antiviral responses are differentially regulated. In this report, we identified RAVER1 as a MDA5-associated protein, which promotes the binding of MDA5 to its ligand and specifically regulates MDA5-but not RIG-I-mediated induction of downstream antiviral genes.
Several lines of evidences suggest that RAVER1 specifically regulates MDA5 but not RIG-I activity. high doses inhibited the activation. One possible reason is that high doses of RAVER1 caused cell death, which could be seen under microscope as well as from reduced levels of b-actin by immunoblot analysis. Alternatively, a proper ratio between RAVER1 and MDA5 may be important for the activation of MDA5. Too much RAVER1 may cause oligomerization of RAVER1 and coverage of MDA5, which makes MDA5 unavailable to bind to downstream signaling components, and therefore, inhibits MDA5-mediated signaling. Similar observations have been obtained from some other well-known molecules. For example, IKKg is a regulatory subunit required for IKK kinase activation. However, overexpression of IKKg inhibits IKK-mediated NF-kB activation. Third, it has been shown that MDA5 recognizes long poly(I:C) whereas RIG-I recognizes short poly(I:C) and 5 ′ ppp-ssRNA, and both MDA5 and RIG-I respond to SeV infection. Our results indicated that knockdown of RAVER1 inhibited SeV-and long poly(I:C)-but not short poly(I:C)-or 5 ′ ppp-ssRNA-induced activation of the IFN-b promoter, IRF3 and NF-kB. These findings demonstrate that RAVER1 specifically regulates MDA5-but not RIG-I-mediated signaling pathways.
Previously, it has been demonstrated that the activity of RIG-I is heavily regulated by post-translational modifications, such as polyubiquitination and phosphorylation (Arimoto et al., 2007; Gack et al., 2007; Okabe et al., 2009; Nistal-Villan et al., 2010; Yang et al., 2011; Wang et al., 2012) . Since RAVER1 is not structurally related to known enzymes, we investigated whether RAVER1 can modulate the interaction between MDA5 and its ligand. We found that RAVER1 itself did not bind to poly(I:C), but markedly enhanced the binding of MDA5 but not RIG-I to poly(I:C). This provides a mechanistic explanation on how RAVER1 acts as a coactivator of MDA5-mediated signaling. In light of this observation, a recent report has identified the dsRNA binding protein PACT as a cellular activator of RIG-I (Kok et al., 2011) . Taken together, we conclude that differential utilization of coactivators contributes, in some degree, to the specificity of RLR-mediated antiviral innate immune responses.
Materials and methods
Reagents
Long poly(I:C) (1.5-8 kb) (InvivoGen), short poly(I:C) (0.2-1 kb) (InvivoGen), mouse monoclonal antibodies against FLAG (Sigma), HA (Covance), b-actin (Sigma), phosphor-IkBa (Cell Signaling Technology), rabbit polyclonal antibodies against IRF3 and phospho-IRF3 (Santa Cruz Biotechnology), iQ SYBR Green Real-Time Supermix (Bio-Rad), Gamma Bind G Plus-Sepharose (Amersham Biosciences) and M-MLV reverse transcriptase (Invitrogen) were purchased from the indicated manufacturers. 5 ′ ppp-RNA was prepared by in vitro transcription. The 293 cells, HCT116 cells, SeV, GFP-NDV, HSV-1 and anti-MDA5 serum were previously described (Xu et al., 2005; Diao et al., 2007; Lei et al., 2010) . EMCV was provided by Dr Hanchun Yang (China Agricultural University). Mouse anti-RAVER1 serum was raised against recombinant human RAVER1 fragment (aa1-320).
Protein purification and mass spectrometry analysis A pCTAP-MDA5 plasmid, in which MDA5 cDNA was inframe fused to the C-terminal CBP and SBP tags in the pCTAP-A plasmid (Stratagene), was constructed by standard molecular biology techniques. The 293 cells (5 × 10 8 ) stably transfected with pCTAP-MDA5 were collected and the cell lysate was subjected to TAP procedures with the interplay Mammalian TAP System (Stratagene). The purified MDA5-associated proteins were digested by trypsin in solution. The tryptic peptides were analyzed by HPLC-ESI/MS/MS with a Thermo Finnigan LTQ adapted for nanospray ionization. The tandem spectra were searched against Homo sapiens National Center for Biotechnology Information reference database using the SEQUEST. Results were filtered by Xcorr +1 . 1.9, +2 . 2.2, +3 . 3.5, sp . 500, Deltcn . 0.1, Rsp ≤ 5. Plasmid constructs NF-kB, Nifty, ISRE, and the IFN-b promoter luciferase reporter plasmids, mammalian expression plasmids for HA-or Flag-tagged RIG-I, MDA5 and the deletion mutants of RIG-I and MDA5 were previously described (Xu et al., 2005; Diao et al., 2007; Zhong et al., 2008; Wang et al., 2010; Ran et al., 2011; He et al., 2013; Zhang et al., 2012) . Mammalian expression plasmids for human Flag-or HA-tagged RAVER1 were constructed by standard molecular biology techniques.
Transfection and reporter assays
The 293 cells were seeded on 24-well dishes and transfected the next day by standard calcium phosphate precipitation. To normalize for transfection efficiency, 0.02 mg of pRL-TK (Renilla luciferase) reporter plasmid was added to each transfection. Luciferase assays were performed using a dual-specific luciferase assay kit (Promega). Firefly luciferase activities were normalized based on Renilla luciferase activities. All reporter assays were repeated at least three times. Coimmunoprecipitation, immunoblot analysis, VSV plaque assays, NDV assays and in vitro poly(I:C) pull-down assays
These experiments were performed as described (Xu et al., 2005; Zhong et al., 2008; Li et al., 2009 Li et al., , 2012 Li et al., 2011; Chen et al., 2012) .
RNAi experiments
Double-strand oligonucleotides corresponding to the target sequences were cloned into the pSuper.retro RNAi plasmid (Oligoengine). The target sequences for human RAVER1 cDNA were as follows: #1: 5 ′ -AGTCGGACCTGCTGGGCAA-3 ′ ; #2: 5 ′ -TC AGAGGCCTCCAGAAAGA-3 ′ ; #3: 5 ′ -CAGTAAGGCAATCGGCTCT-3 ′ and #4: 5 ′ -CTGAAGCGGAAGAGGATTT-3 ′ . The TRIF-RNAi plasmid was previously described (Han et al., 2010) .
Real-time PCR analysis
Total RNA was isolated from cells using Trizol reagent (TaKaRa) and subjected to real-time PCR analysis to measure mRNA expression. Real-time PCR was performed using iQ SYBR Green Supermix and analyzed on C1000 Thermal Cycler (Bio-Rad). Gene-specific primer sequences were as follows: IFNB1, forward: 5 ′ -TTGTTGA 
RNAi-induced stable cells
The 293 cells were transduced with two packaging plasmids pGag-Pol and pVSV-G and the GFP-RNAi control or RAVER1-RNAi retroviral plasmid by calcium phosphate precipitation. Cells were washed 12 h after transduction and new medium without antibiotics was added for 24 h. The recombinant viruscontaining medium was filtered and used to infect 293 cells or HCT116 cells in the presence of polybrene (4 mg/ml). The infected 293 cells or HCT116 cells were selected with puromycin (0.5 mg/ml) for 2 weeks before additional experiments were performed.
In vitro binding assays
The RAVER1 and MDA5 proteins were synthesized with a TNT Quick-coupled Transcription/Translation System kit (Promega) following instructions of the manufacturer. The in vitro translated RAVER1 and MDA5 protein products (20 ml each) were mixed. The mixture was immunoprecipitated with anti-MDA5 and the immunoprecipitates were analyzed by immunoblotting with anti-RAVER1 or anti-MDA5.
